Showing 66,961 - 66,980 results of 103,189 for search '(( e point decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.82s Refine Results
  1. 66961
  2. 66962
  3. 66963
  4. 66964
  5. 66965

    Model Studies of Methacrylate Chain Transfer Polymerization Mediated by Cationic Zirconocene <i>tert</i>-Butyl Enolate by Bing Lian (1915672)

    Published 2005
    “…In this case, a moderate decrease in the molecular weight of the PMMAs is observed. …”
  6. 66966

    Data_Sheet_1_Estrogen Regulates Glucose Metabolism in Cattle Neutrophils Through Autophagy.ZIP by Xinbo Wang (1430794)

    Published 2021
    “…<p>Hypoglycemia resulting from a negative energy balance (NEB) in periparturient cattle is the major reason for a reduced glycogen content in polymorphonuclear neutrophils (PMNs). …”
  7. 66967

    Data_Sheet_1_Hesperetin but not ellagic acid increases myosin heavy chain expression and cell fusion in C2C12 myoblasts in the presence of oxidative stress.docx by Iris Cuijpers (19520122)

    Published 2024
    “…An oxidative stress-induced decrease in differentiation capacity of muscle satellite cells is a key factor in this process. …”
  8. 66968
  9. 66969

    Incident light intensities and cellular parameters. by Benjamin Schellenberger Costa (461158)

    Published 2013
    “…O: no significant difference between WT and aureochrome 1a silenced strain; −: significant decrease in aureochrome 1a silenced strain compared to WT; +: significant increase in aureochrome 1a silenced strain compared to WT.…”
  10. 66970

    Figure 6 by Milena Raffi (24059)

    Published 2013
    “…<p>Regression analysis for representation of optic flow in M1R. Same data set as <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0000200#pone-0000200-g004" target="_blank">Figs. 4</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0000200#pone-0000200-g005" target="_blank">5</a>. …”
  11. 66971

    pri–miRNA abundance and Pol II occupancy at <i>MIR</i> genes in <i>pwr-1</i> and <i>pwr-2</i>. by Rae Eden Yumul (101996)

    Published 2013
    “…(C) Real-time RT-PCR analysis of other pri-miRNAs. A general decrease was observed in pri-miRNA transcript levels in both <i>pwr</i> alleles. …”
  12. 66972

    Example of staircases leading to threshold calculation. by Paulo Roney Kilpp Goulart (404481)

    Published 2013
    “…Each point represents the distance, in u′v′ units, between the chromaticity points that define the target and background. …”
  13. 66973

    H3K27me3 levels show differences across SMN differentiation in <i>Suz12GT</i> cells compared to wt cells. by Seraphim R. Thornton (647875)

    Published 2014
    “…Day 0 (ESC) is at top, while day 5 SMN is shown at bottom. (<b>E</b>) H3K27me3 and H3K4me3 ChIP-seq tracks for <i>Gata6</i> promoter (left); <i>Bmp2</i> promoter (middle); and the <i>HoxA</i> cluster (right) show that H3K27me3 levels change (increase, decrease, or stay the same, depending upon locus) in <i>Suz12<sup>GT</sup></i> cells upon differentiation. …”
  14. 66974

    DataSheet_1_Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phas... by Brad Nakamura (19273060)

    Published 2024
    “…This analysis describes the outcomes of a sub-cohort of four LGSOC patients treated with IP cisplatin 10.5 mg/m<sup>2</sup>, doxorubicin 2.1 mg/m<sup>2</sup> PIPAC q4-6 weeks. …”
  15. 66975

    Origanum Syriacum Inhibits Proliferation, Migration, Invasion and Induces Differentiation of Human Aortic Smooth Muscle Cells by AlDisi, Sara

    Published 2014
    “…Cardiovascular diseases (CVDs) are still the number one cause of morbidity and mortality both in Qatar and worldwide. A major risk factor of CVDs is atherosclerosis, the hardening of blood vessels caused by decreased diameter and formation of plaque. …”
    Get full text
    Get full text
  16. 66976

    Effect of <i>LipB</i> Disruption on Lipoic Acid Levels and PDH-E2 Lipoylation by Svenja Günther (37469)

    Published 2007
    “…<div><p>(A) WT 3D7 and <i>LipB</i>KO mutants were analysed for their LA content. …”
  17. 66977

    DataSheet2_PK-PD integration of enrofloxacin and cefquinome alone and in combination against Klebsiella pneumoniae using an in vitro dynamic model.ZIP by Yanzhe Wei (8980829)

    Published 2023
    “…The dynamic time-kill curves indicated that enrofloxacin and cefquinome had bactericidal and bacteriostatic activities, respectively at ≥1.5 mg/L (single-dose) and 4 mg/L (8 h split-dose) causing a decrease in bacterial counts of ≥4.45 and >2 log<sub>10</sub> CFU/mL. …”
  18. 66978

    DataSheet1_PK-PD integration of enrofloxacin and cefquinome alone and in combination against Klebsiella pneumoniae using an in vitro dynamic model.ZIP by Yanzhe Wei (8980829)

    Published 2023
    “…The dynamic time-kill curves indicated that enrofloxacin and cefquinome had bactericidal and bacteriostatic activities, respectively at ≥1.5 mg/L (single-dose) and 4 mg/L (8 h split-dose) causing a decrease in bacterial counts of ≥4.45 and >2 log<sub>10</sub> CFU/mL. …”
  19. 66979

    DataSheet3_PK-PD integration of enrofloxacin and cefquinome alone and in combination against Klebsiella pneumoniae using an in vitro dynamic model.PDF by Yanzhe Wei (8980829)

    Published 2023
    “…The dynamic time-kill curves indicated that enrofloxacin and cefquinome had bactericidal and bacteriostatic activities, respectively at ≥1.5 mg/L (single-dose) and 4 mg/L (8 h split-dose) causing a decrease in bacterial counts of ≥4.45 and >2 log<sub>10</sub> CFU/mL. …”
  20. 66980

    Table1_PK-PD integration of enrofloxacin and cefquinome alone and in combination against Klebsiella pneumoniae using an in vitro dynamic model.xlsx by Yanzhe Wei (8980829)

    Published 2023
    “…The dynamic time-kill curves indicated that enrofloxacin and cefquinome had bactericidal and bacteriostatic activities, respectively at ≥1.5 mg/L (single-dose) and 4 mg/L (8 h split-dose) causing a decrease in bacterial counts of ≥4.45 and >2 log<sub>10</sub> CFU/mL. …”